Mr Warden was a founding partner of Yetter, Warden & Coleman. In his 23 years of practice, he has represented both plaintiffs and defendants in cases pertaining to antitrust, securities violations, trade secrets, patents, and other business and technology litigation.
Jeff Morhet, chairman and CEO of InNexus Biotechnology, said: “I am pleased to have David join our team as a director on our board. His broad legal experience and, in particular, his expertise in patent law will prove valuable as we continue to expand and fortify our intellectual property position.”